Mm Cheng Xue (Cheng Xue)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 19

Top Topics

Aortic Dissection

Replacement Therapy

Editorial Comment

Top Venues

Clinical journal of the American Society of Nephrology : CJASN

Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Fangzheng Cui, Jieting Zhang, Mengna Ruan, Yunhui Lu, Jun Wu, Zewei Chen, Mm Cheng Xue, Mm Jing Xu, Mm Zhiguo Mao
Prognostic Assessment of Histopathologic Lesions in Patients with Community-Acquired AKI with Biopsy-Proven Acute Tubular Necrosis. Kidney360 5 (7) (2024)
Fangzheng Cui, Jieting Zhang, Mengna Ruan, Yunhui Lu, Jun Wu, Zewei Chen, Mm Cheng Xue, Mm Jing Xu, Mm Zhiguo Mao
Prognostic Assessment of Histopathologic Lesions in Patients with Community-Acquired AKI with Biopsy-Proven Acute Tubular Necrosis. Kidney360 5 (7) (2024)
Fangzheng Cui, Jieting Zhang, Mengna Ruan, Yunhui Lu, Jun Wu, Zewei Chen, Mm Cheng Xue, Mm Jing Xu, Mm Zhiguo Mao
Prognostic Assessment of Histopathologic Lesions in Patients with Community-Acquired AKI with Biopsy-Proven Acute Tubular Necrosis. Kidney360 5 (7) (2024)
Fangzheng Cui, Jieting Zhang, Mengna Ruan, Yunhui Lu, Zewei Chen, Mm Cheng Xue, Jun Wu, Mm Jing Xu, Mm Zhiguo Mao
Prognostic Assessment of Histopathologic Lesions in Patients with Community-Acquired Acute Kidney Injury with Biopsy-Proven Acute Tubular Necrosis. Kidney360 (2024)
Fangzheng Cui, Jieting Zhang, Mengna Ruan, Yunhui Lu, Jun Wu, Zewei Chen, Mm Cheng Xue, Mm Jing Xu, Mm Zhiguo Mao
Prognostic Assessment of Histopathologic Lesions in Patients with Community-Acquired AKI with Biopsy-Proven Acute Tubular Necrosis. Kidney360 5 (7) (2024)
Mm Cheng Xue, Bo Yang, Xiaojing Tang, Yufei Deng, Hua Li, Bing Dai
Obstructive uropathy complicated by acute aortic dissection. CEN case reports (2024)
Linxi Huang, Junjie Hu, Mm Cheng Xue, Jiarong Ding, Zhiyong Guo, Bing Yu
Vascular calcification on the risk of kidney stone: a meta-analysis. Renal failure 45 (1) (2023)
Linxi Huang, Junjie Hu, Mm Cheng Xue, Jiarong Ding, Zhiyong Guo, Bing Yu
Vascular calcification on the risk of kidney stone: a meta-analysis. Renal failure 45 (1) (2023)
Linxi Huang, Junjie Hu, Mm Cheng Xue, Jiarong Ding, Zhiyong Guo, Bing Yu
Vascular calcification on the risk of kidney stone: a meta-analysis. Renal failure 45 (1) (2023)
Xiaoling Luo, Mm Jing Xu, Shoulian Zhou, Mm Cheng Xue, Zewei Chen, Mm Zhiguo Mao
Influence of SGLT2i and RAASi and Their Combination on Risk of Hyperkalemia in DKD: A Network Meta-Analysis. Clinical journal of the American Society of Nephrology : CJASN (2023)
Mm Cheng Xue, Bing Dai
Potential factors associated with a long-term duration of B-cell depletion after using rituximab in patients with nephrotic syndrome. Pediatric nephrology (Berlin, Germany) (2023)
Mm Cheng Xue, Bo Yang, Jing Xu, Zhiguo Mao
Golden mean of serum uric acid level on the risk of kidney function decline. Clinical and experimental nephrology (2023)
Jing Xu, Mm Cheng Xue, Fangzheng Cui, Jiayi Lv, Yanqing Jie, Lingling Liu, Qianwen Zheng, Haigu Fang, Xiangdong Li, Bing Dai, Jing Chen, Zhiguo Mao
A pilot study of intensive short-time continuous renal replacement therapy to substitute maintenance hemodialysis during transitional period of COVID-19. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy (2023)
Mm Cheng Xue, Chenchen Zhou, Bo Yang, Xiaofei Ye, Jing Xu, Yunhui Lu, Xiaohua Hu, Jia Chen, Xiaoling Luo, Liming Zhang, Changlin Mei, Zhiguo Mao
A Nomogram to Identify Hyperkalemia Risk in Patients with Advanced CKD. Kidney360 3 (10) (2022)
Mm Cheng Xue, Chenchen Zhou, Bo Yang, Xiaofei Ye, Jing Xu, Yunhui Lu, Xiaohua Hu, Jia Chen, Xiaoling Luo, Liming Zhang, Changlin Mei, Zhiguo Mao
A Nomogram to Identify Hyperkalemia Risk in Patients with Advanced CKD. Kidney360 3 (10) (2022)
Mm Cheng Xue, Chenchen Zhou, Bo Yang, Xiaofei Ye, Jing Xu, Yunhui Lu, Xiaohua Hu, Jia Chen, Xiaoling Luo, Liming Zhang, Changlin Mei, Zhiguo Mao
A Nomogram to Identify Hyperkalemia Risk in Patients with Advanced CKD. Kidney360 3 (10) (2022)
Mm Cheng Xue, Chenchen Zhou, Bo Yang, Xiaofei Ye, Jing Xu, Yunhui Lu, Xiaohua Hu, Jia Chen, Xiaoling Luo, Liming Zhang, Changlin Mei, Zhiguo Mao
A Nomogram to Identify Hyperkalemia Risk in Patients with Advanced CKD. Kidney360 3 (10) (2022)
Mm Cheng Xue, Chenchen Zhou, Bo Yang, Xiaofei Ye, Jing Xu, Yunhui Lu, Xiaohua Hu, Jia Chen, Xiaoling Luo, Liming Zhang, Changlin Mei, Zhiguo Mao
A Nomogram to Identify Hyperkalemia Risk in Patients with Advanced CKD. Kidney360 3 (10) (2022)
Mm Cheng Xue, Bo Yang, Jing Xu, Chenchen Zhou, Liming Zhang, Xiang Gao, Bing Dai, Shengqiang Yu, Zhiguo Mao, Changlin Mei, Chenggang Xu
Efficacy and safety of rituximab in adult frequent-relapsing or steroid-dependent minimal change disease or focal segmental glomerulosclerosis: a systematic review and meta-analysis. Clinical kidney journal 14 (4) (2020)